What does Vanda Pharmaceuticals, Inc. do?

Jun 22 2025 06:45 PM IST
share
Share Via
Vanda Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing therapies for unmet medical needs. As of March 2025, it reported net sales of $50 million and a net loss of $29 million, with a market cap of $264.62 million.
Overview:
Vanda Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of therapies to address unmet medical needs within the Pharmaceuticals & Biotechnology industry.

Financial Snapshot:
- Most recent Net Sales: 50 Million (Quarterly Results - Mar 2025)
- Most recent Net Profit: -29 Million (Quarterly Results - Mar 2025)
- Market-cap: USD 264.62 Million (Micro Cap)

Key Metrics:
- P/E: NA (Loss Making)
- Industry P/E: NA
- Dividend Yield: 0.00%
- Debt Equity: -0.66
- Return on Equity: -8.65%
- Price to Book: 0.52

Contact Details:
- Address: 2200 Pennsylvania Ave NW Ste 300E, WASHINGTON DC: 20037-1754
- Tel: 1 202 7343400
- Fax: 1 202 2961450
- Website: http://www.vandapharma.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News